Literature DB >> 22425271

Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps.

Krishna C Vemulapalli1, Douglas K Rex.   

Abstract

BACKGROUND: Serrated polyposis syndrome (SPS) is a rare condition of multiple serrated colorectal polyps and cancers. Colorectal cancer risk is increased in SPS.
OBJECTIVE: We determined the prevalence of SPS in a cohort of patients with large (≥ 2 cm) sessile colorectal polyps and the rate at which the diagnosis was made by the clinicians.
DESIGN: Review of patient care database. The 2010 World Health Organization (WHO) criteria were used to identify cases of SPS.
SETTING: Tertiary academic center. PATIENTS: 529 consecutive patients referred for endoscopic resection of a sessile colorectal polyp ≥ 2 cm. MAIN OUTCOME MEASUREMENTS: Prevalence of SPS in the cohort and frequency with which the referring physician and the endoscopist recognized SPS.
RESULTS: Of the 529 patients, 20 (4%) met the WHO criteria for SPS. Only 1 of these cases was suspected by a referring physician. Twelve cases (60%) were either diagnosed or suspected by the endoscopist at our center. Compared with all other patients without SPS, those with SPS were more likely to have an index lesion (the lesion that led to referral) that was serrated (60% vs 3.8%), to have a cecal or ascending colon index lesion (70% vs 45%), and to be current smokers (42% vs 15%). Including the first colonoscopy to remove the index lesion and 26 follow-up colonoscopies, the endoscopist at our center removed 183 serrated polyps from the 20 patients with SPS; of those polyps, 68 were >1 cm. Three patients were referred for surgical resection of involved colon. Eighteen of the 20 patients with SPS met the WHO criterion of 5 serrated polyps proximal to the sigmoid, of which 2 are >1 cm. Failure to recognize SPS by the referring physician was at least partly related to unrecognized serrated lesions. Failure to recognize SPS by the endoscopist at our institution was the result of not systematically applying WHO criteria to the polyp findings. LIMITATIONS: Retrospective study.
CONCLUSIONS: SPS was common in a cohort of patients with large sessile colorectal polyps, and it was frequently unrecognized. These data suggest the need for better detection of serrated lesions, better awareness of SPS, and more consistent application of SPS criteria to the polyp findings of individual patients.
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22425271     DOI: 10.1016/j.gie.2012.01.033

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  14 in total

1.  Serrated polyposis: the problem of definition and its relationship to the population at risk for syndrome-related colorectal cancer.

Authors:  Joanne P Young; Timothy J Price; Susan Parry
Journal:  Transl Cancer Res       Date:  2017-12       Impact factor: 1.241

2.  Sessile serrated adenomas: why conventional endoscopy is okay for unconventional polyps.

Authors:  Stephen J Lanspa; Henry T Lynch
Journal:  Dig Dis Sci       Date:  2014-12       Impact factor: 3.199

Review 3.  Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management.

Authors:  Priyanka Kanth; Jade Grimmett; Marjan Champine; Randall Burt; N Jewel Samadder
Journal:  Am J Gastroenterol       Date:  2017-08-08       Impact factor: 10.864

Review 4.  Diagnosis, epidemiology and management of serrated polyposis syndrome: a comprehensive review of the literature.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Dimitrios K Christodoulou
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis.

Authors:  Christophe Rosty; Michael D Walsh; Rhiannon J Walters; Mark Clendenning; Sally-Ann Pearson; Mark A Jenkins; Aung Ko Win; John L Hopper; Kevin Sweet; Wendy L Frankel; Melyssa Aronson; Steve Gallinger; Jack Goldblatt; Kathy Tucker; Sian Greening; Michael R Gattas; Sonja Woodall; Julie Arnold; Neal I Walker; Susan Parry; Joanne P Young; Daniel D Buchanan
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

6.  Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort.

Authors:  Kory W Jasperson; Priyanka Kanth; Anne C Kirchhoff; Darcy Huismann; Amanda Gammon; Wendy Kohlmann; Randall W Burt; N Jewel Samadder
Journal:  Dis Colon Rectum       Date:  2013-11       Impact factor: 4.585

7.  Quantum dots targeted to vascular endothelial growth factor receptor 2 as a contrast agent for the detection of colorectal cancer.

Authors:  Jordan L Carbary-Ganz; Jennifer K Barton; Urs Utzinger
Journal:  J Biomed Opt       Date:  2014-08       Impact factor: 3.170

Review 8.  Serrated polyps: clinical implications and future directions.

Authors:  Michael Tadros; Joseph C Anderson
Journal:  Curr Gastroenterol Rep       Date:  2013-09

9.  Serrated colon polyps as precursors to colorectal cancer.

Authors:  Seth Sweetser; Thomas C Smyrk; Frank A Sinicrope
Journal:  Clin Gastroenterol Hepatol       Date:  2012-12-23       Impact factor: 11.382

10.  Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome: A Case Report and Literature Review.

Authors:  Mahmoud M Mansour; Zachary D Smith; Yezaz Ghouri; Veysel Tahan
Journal:  Cureus       Date:  2021-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.